Mandorfer M, Abraldes J, Berzigotti A
JHEP Rep. 2025; 7(3):101300.
PMID: 40034396
PMC: 11874574.
DOI: 10.1016/j.jhepr.2024.101300.
Huang Y, Li J, Liu C, Song D, Zhu C, Ren Y
MedComm (2020). 2025; 6(3):e70123.
PMID: 40027150
PMC: 11868440.
DOI: 10.1002/mco2.70123.
Garcia Izquierdo B, Martinez-Urbistondo D, Guadalix S, Pastrana M, Bajo Buenestado A, Colina I
J Clin Med. 2025; 14(4).
PMID: 40004749
PMC: 11856594.
DOI: 10.3390/jcm14041218.
Kjaer M, Jorgensen A, Fjelstrup S, Dupont D, Bus C, Eriksen P
Biomolecules. 2025; 15(2).
PMID: 40001558
PMC: 11852711.
DOI: 10.3390/biom15020255.
Patmore L, van Eekhout K, Koc O, de Knegt R, Janssen H, Brouwer W
Liver Int. 2025; 45(3):e70042.
PMID: 39999021
PMC: 11855902.
DOI: 10.1111/liv.70042.
MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC.
Stockinger E, Luxenburger H, Bettinger D, Berlin C, Obwegs D, Sagar
Hepatol Commun. 2025; 8(10).
PMID: 39992088
PMC: 11458167.
DOI: 10.1097/HC9.0000000000000532.
Non‑high‑density lipoprotein cholesterol to high‑density lipoprotein cholesterol ratio as a biomarker for liver health: Insights from National Health and Nutrition Examination Survey data.
Hong L, Sun Y, Lu X, Xu X
Biomed Rep. 2025; 22(4):61.
PMID: 39990999
PMC: 11843208.
DOI: 10.3892/br.2025.1939.
The predictive value of fibrosis profiles for hepatitis E virus-related liver failure among hospitalized patients with acute hepatitis E: a retrospective cohort study.
Dong R, Huang L, Chen L, Xue H, Shao J, Ye C
BMC Infect Dis. 2025; 25(1):255.
PMID: 39988662
PMC: 11849170.
DOI: 10.1186/s12879-025-10632-z.
Analysis of the prognostic efficacy of syndecan-1 for patients with ACLF and its functional role in liver regeneration.
He Y, Zhang X, Yao Y, Li J, Fu S, Feng Y
BMC Med. 2025; 23(1):104.
PMID: 39985044
PMC: 11846419.
DOI: 10.1186/s12916-025-03931-4.
Bulevirtide in Chronic Hepatitis D Patients Awaiting Liver Transplantation Results From a French Multicentric Retrospective Study.
Meszaros M, Hilleret M, Dumortier J, DAlteroche L, Abergel A, Latournerie M
Liver Int. 2025; 45(3):e70033.
PMID: 39960163
PMC: 11831879.
DOI: 10.1111/liv.70033.
Optimal use of red cell volume distribution width-to-platelet ratio to exclude cirrhosis in patients with chronic hepatitis B.
Yu H, Li C, Li M, Liang Z, Smayi A, Yang B
Liver Res. 2025; 7(3):244-251.
PMID: 39958380
PMC: 11791909.
DOI: 10.1016/j.livres.2023.08.006.
Effects of dietary live microbes intake on a newly proposed classification system for steatotic liver disease.
Dai Z, Bao Z, Lin H, Yang Q, Huang J, Zhang X
Sci Rep. 2025; 15(1):5595.
PMID: 39955369
PMC: 11829948.
DOI: 10.1038/s41598-025-88420-7.
Drug-target Mendelian randomisation applied to metabolic dysfunction-associated steatotic liver disease: opportunities and challenges.
Luo S, Zheng M, Wong V, Au Yeung S
eGastroenterology. 2025; 2(4):e100114.
PMID: 39944268
PMC: 11770435.
DOI: 10.1136/egastro-2024-100114.
CLivD score modifies FIB-4 performance in liver fibrosis detection in the US general population.
Aberg F, Laaperi M, Mannisto V
eGastroenterology. 2025; 1(2):e100035.
PMID: 39944006
PMC: 11770440.
DOI: 10.1136/egastro-2023-100035.
Two years on, a perspective on MAFLD.
Eslam M, George J
eGastroenterology. 2025; 1(2):e100019.
PMID: 39943998
PMC: 11770426.
DOI: 10.1136/egastro-2023-100019.
Evaluating Pediatric NAFLD with Controlled Attenuation Parameter: A Comprehensive Narrative Review.
Arteaga I, Chacon C, Martinez-Escude A, Rojano I, Diez-Fadrique G, Carmona-Cervello M
Diagnostics (Basel). 2025; 15(3).
PMID: 39941229
PMC: 11816681.
DOI: 10.3390/diagnostics15030299.
Impact of shear wave elastography and attenuation imaging for predicting life-threatening event in patients with metabolic dysfunction-associated steatotic liver disease.
Fujiwara Y, Kuroda H, Abe T, Nagasawa T, Nakaya I, Ito A
Sci Rep. 2025; 15(1):4547.
PMID: 39915518
PMC: 11802924.
DOI: 10.1038/s41598-025-87974-w.
Iron overload is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes.
Qu H, Zhou L, Wang J, Tang D, Zhang Q, Shi J
Obesity (Silver Spring). 2025; 33(3):490-499.
PMID: 39915040
PMC: 11897857.
DOI: 10.1002/oby.24236.
Liver diseases: epidemiology, causes, trends and predictions.
Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z
Signal Transduct Target Ther. 2025; 10(1):33.
PMID: 39904973
PMC: 11794951.
DOI: 10.1038/s41392-024-02072-z.
Successful Example of Implementing Screening of Liver Fibrosis in Specialist Diabetes Care.
Tajudin M, Hagstrom H, Rossner S
Gastro Hep Adv. 2025; 4(3):100577.
PMID: 39902461
PMC: 11788731.
DOI: 10.1016/j.gastha.2024.10.017.